drugset / Trial / NCT02083107

Comparison Between Rectal & Sublingual Misoprostol Before Caesarian Section To Reduce Intra & Post-Operative Blood Loss

NCT02083107

Phase 2/3 Completed 636 enrolled Ain Shams University
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of the work is to evaluate \& compare the effectiveness of rectally administered PGE1 synthetic analogue (misoprostol) 400 microgram versus sublingually administered misoprostol before caesarean section to decrease blood loss during and after the operation.

Timeline

Start
2013-02
Primary completion
2014-02
Completion
2014-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Other

Indications

No indication recorded.